AI-generated summary
The authors tested whether red light photobiomodulation (630 nm) improved anaerobic performance in 15 well-trained male cyclists using a randomized, double-blinded, placebo-controlled crossover design with a 30-second Wingate test. They report no statistically significant differences between photobiomodulation and placebo sessions for any measured variable, with only small effect sizes detected for time to peak power and explosive strength.
- Participants
- 15
- Who or what was studied
- Fifteen healthy male road or mountain bike cyclists who were well trained
- Wavelengths
- 630 nm
- Limits stated in the abstract
- The abstract describes a small sample of 15 athletes and reports only small effect sizes, so the study may not have had power to detect modest effects.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630 nm
- Energy density (fluence)
- 4.6 J/cm2
- Total energy
- 6 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Crossover study, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.